Publications

Detailed Information

Radiosurgery for large cerebral arteriovenous malformations

DC Field Value Language
dc.contributor.authorYang, Seung-Yeob-
dc.contributor.authorKim, Dong Gyu-
dc.contributor.authorChung, Hyun-Tai-
dc.contributor.authorPaek, Sun Ha-
dc.contributor.authorHan, Dae Hee-
dc.contributor.authorPark, Jae Hyo-
dc.date.accessioned2012-06-27T07:54:51Z-
dc.date.available2012-06-27T07:54:51Z-
dc.date.issued2009-02-
dc.identifier.citationACTA NEUROCHIRURGICA; Vol.151(2); 113-124ko_KR
dc.identifier.issn0001-6268-
dc.identifier.urihttps://hdl.handle.net/10371/77644-
dc.description.abstractRadiosurgery is an effective treatment option for patients with small to medium sized arteriovenous malformations. However, it is not generally accepted as an effective tool for larger (> 14 cm(3)) arteriovenous malformations because of low obliteration rates. The authors assessed the applicability and effectiveness of radiosurgery for large arteriovenous malformations. We performed a retrospective study of 46 consecutive patients with more than 14 ml of arteriovenous malformations who were treated with radiosurgery using a linear accelerator and gamma knife (GK). They were grouped according to their initial clinical presentation-17 presented with and 29 without haemorrhage. To assess the effect of embolization, these 46 patients were also regrouped into two subgroups-25 with and 21 without preradiosurgical embolization. Arteriovenous malformations found to have been incompletely obliterated after 3-year follow-up neuroimaging studies were re-treated using a GK. The mean treatment volume was 29.5 ml (range, 14.0-65.0) and the mean marginal dose was 14.1 Gy (range, 10.0-20.0). The mean clinical follow-up periods after initial radiosurgery was 78.1 months (range, 34.0-166.4). Depending on the results of the angiography, 11 of 33 patients after the first radiosurgery and three of four patients after the second radiosurgery showed complete obliteration. Twenty patients received the second radiosurgery and their mean volume was significantly smaller than their initial volume (P = 0.017). The annual haemorrhage rate after radiosurgery was 2.9% in the haemorrhage group (mean follow-up 73.3 months) and 3.1% in the nonhaemorrhage group (mean follow-up 66.5 months) (P = 0.941). Preradiosurgical embolization increased the risk of haemorrhage for the nonhaemorrhage group (HR, 28.03; 95% CI, 1.08-6,759.64; P = 0.039), whereas it had no effect on the haemorrhage group. Latency period haemorrhage occurred in eight patients in the embolization group, but in no patient in the nonembolization group (P = 0.004). Radiosurgery may be a safe and effective arteriovenous malformation treatment method that is worth considering as an alternative treatment option for a large arteriovenous malformation.ko_KR
dc.language.isoenko_KR
dc.publisherSPRINGER WIENko_KR
dc.subjectArteriovenous malformationko_KR
dc.subjectRadiosurgeryko_KR
dc.subjectObliterationko_KR
dc.subjectEmbolizationko_KR
dc.subjectHaemorrhageko_KR
dc.titleRadiosurgery for large cerebral arteriovenous malformationsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor양승엽-
dc.contributor.AlternativeAuthor김동규-
dc.contributor.AlternativeAuthor정현태-
dc.contributor.AlternativeAuthor백선하-
dc.contributor.AlternativeAuthor박재효-
dc.contributor.AlternativeAuthor한대희-
dc.identifier.doi10.1007/s00701-008-0173-5-
dc.citation.journaltitleACTA NEUROCHIRURGICA-
dc.description.citedreferenceMAJOR O, 2007, PROG NEUROL SURG, V20, P375-
dc.description.citedreferenceStapf C, 2006, NEUROLOGY, V66, P1350-
dc.description.citedreferenceZabel-Du Bois A, 2006, INT J RADIAT ONCOL, V64, P1049, DOI 10.1016/j.ijrobp.2005.09.021-
dc.description.citedreferenceSirin S, 2006, NEUROSURGERY, V58, P17, DOI 10.1227/01.NEU.0000190653.42970.6B-
dc.description.citedreferenceVernimmen FJAI, 2005, INT J RADIAT ONCOL, V62, P44, DOI 10.1016/j.ijrobp.2004.09.008-
dc.description.citedreferenceMaruyama K, 2005, NEW ENGL J MED, V352, P146-
dc.description.citedreferenceVeznedaroglu E, 2004, NEUROSURGERY, V55, P519, DOI 10.1227/01.NEU.000013428.5.41701.83-
dc.description.citedreferenceTaylor CL, 2004, J NEUROSURG, V100, P810-
dc.description.citedreferenceLindvall P, 2003, NEUROSURGERY, V53, P1036-
dc.description.citedreferencePollock BE, 2003, NEUROSURGERY, V52, P1291, DOI 10.1227/01.NEU.0000064800.26214.FE-
dc.description.citedreferenceHan PP, 2003, J NEUROSURG, V98, P3-
dc.description.citedreferencePOLLOCK BE, 2003, NEUROSURGERY, V52, P1296-
dc.description.citedreferenceLINDVALL P, 2003, NEUROSURGERY, V53, P1042-
dc.description.citedreferencePollock BE, 2002, J NEUROSURG, V96, P79-
dc.description.citedreferenceCastel JP, 2001, NEUROCHIRURGIE, V47, P369-
dc.description.citedreferencePan DHC, 2000, J NEUROSURG, V93, P113-
dc.description.citedreferencePollock BE, 2000, INT J RADIAT ONCOL, V48, P817-
dc.description.citedreferenceLindqvist M, 2000, NEUROSURGERY, V46, P803-
dc.description.citedreferenceMiyawaki L, 1999, INT J RADIAT ONCOL, V44, P1089-
dc.description.citedreferencePaulsen RD, 1999, NEUROSURGERY, V44, P991-
dc.description.citedreferenceRedekop G, 1998, J NEUROSURG, V89, P539-
dc.description.citedreferenceTouboul E, 1998, INT J RADIAT ONCOL, V41, P855-
dc.description.citedreferenceEllis TL, 1998, J NEUROSURG, V89, P104-
dc.description.citedreferenceMast H, 1997, LANCET, V350, P1065-
dc.description.citedreferenceSchneider BF, 1997, J NEUROSURG, V87, P352-
dc.description.citedreferenceKihlstrom L, 1997, J NEUROSURG, V86, P589-
dc.description.citedreferenceChang SD, 1997, CLIN NEUROPATHOL, V16, P111-
dc.description.citedreferenceKarlsson B, 1997, NEUROSURGERY, V40, P425-
dc.description.citedreferenceFlickinger JC, 1996, INT J RADIAT ONCOL, V36, P873-
dc.description.citedreferenceGobin YP, 1996, J NEUROSURG, V85, P19-
dc.description.citedreferencePollock BE, 1996, NEUROSURGERY, V38, P652-
dc.description.citedreferencePollock BE, 1996, NEUROSURGERY, V38, P318-
dc.description.citedreferencePOLLOCK BE, 1996, NEUROSURGERY, V38, P659-
dc.description.citedreferenceSORIMACHI T, 1995, NEUROSURGERY, V37, P1041-
dc.description.citedreferenceMATHIS JA, 1995, AM J NEURORADIOL, V16, P299-
dc.description.citedreferenceMARTIN NA, 1995, NEUROVASCULAR SURG, P875-
dc.description.citedreferenceYOUNG WL, 1994, NEUROSURGERY, V35, P389-
dc.description.citedreferenceCOLOMBO F, 1994, NEUROSURGERY, V34, P14-
dc.description.citedreferenceYOUNG WL, 1994, NEUROSURGERY, V35, P395-
dc.description.citedreferenceALRODHAN NRF, 1993, J NEUROSURG, V78, P167-
dc.description.citedreferenceKONDZIOLKA D, 1993, STEREOTACTIC RADIOSU, P136-
dc.description.citedreferenceRAUCH RA, 1992, AM J NEURORADIOL, V13, P303-
dc.description.citedreferenceJUNGREIS CA, 1989, AM J NEURORADIOL, V10, P575-
dc.description.citedreferenceBROWN RD, 1988, J NEUROSURG, V68, P352-
dc.description.citedreferenceBATJER HH, 1988, NEUROSURGERY, V22, P503-
dc.description.citedreferenceHALBACH VV, 1987, AM J NEURORADIOL, V8, P751-
dc.description.citedreferenceSPETZLER RF, 1986, J NEUROSURG, V65, P476-
dc.description.citedreferenceKJELLBERG RN, 1983, NEW ENGL J MED, V309, P269-
dc.description.tc4-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share